Biswajit Das

4PUBLICATIONS
13CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 24, 2026
Slow RNAPII elongation enhances naive pluripotency rewiring while maintaining high replication fork speed.

|Dec 02, 2021
Correction to: Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis.

Debasish Mohapatra, Biswajit Das, Voddu Suresh

|Nov 13, 2021
Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis.

Debasish Mohapatra, Biswajit Das, Voddu Suresh

|Feb 15, 2019
Genome-wide expression analysis reveals six contravened targets of EZH2 associated with breast cancer patient survival.

Kanchan Kumari, Biswajit Das, Amit K Adhya

Pageof 1

Frequent Collaborators

2 joint publications

Voddu Suresh

2 joint publications

Shantibhusan Senapati

1 joint publications

Sara Martín-Vírgala

1 joint publications

Joana Segura